Headlines
-
PALS unite for loneliness
Tuesday | Aug 6 2024TO MARK Loneliness Awareness Week (05-11 Aug), the Pharmaceutical Society of Australia (PSA) has partnered with Pharmacy Addressing Loneliness and Social-isolation (PALS) to launch an unprecedented training program for pharmacists.
-
Butler backs 60DD, as PSA partners up
Monday | Aug 5 2024THE Federal Health Minister Mark Butler called 60-Day Dispensing (60DD) "difficult reform, but good policy" in his opening address at the Pharmaceutical Society of Australia's (PSA) national conference, PSA24, on Fri.
-
PSA celebrates its high achievers
Monday | Aug 5 2024DEDICATED professionals were recognised in front of their peers at the Pharmaceutical Society of Australia's national conference (PSA24) last week.
-
PSA Shark Tank sees innovation thrive
Monday | Aug 5 2024INNOVATION and creativity were in the spotlight at last week's annual PSA24 conference, where clever devices like a needle-less hepatitis screening tool and an AI-powered diabetes platform were showcased during the Pharmacy Shark Tank session.
-
PSA rewards its top professionals
Friday | Aug 2 2024THREE exceptional Australian pharmacists were honoured today by the Pharmaceutical Society of Australia (PSA) during their national conference, PSA24, held in Sydney.
-
Thyroid cancer drug lists
Friday | Aug 2 2024IPSEN Australia's Cabometyx (cabozantinib), a once-daily oral medication for thyroid cancer, is now available on the PBS.
-
T2D drug slows TUD care
Friday | Aug 2 2024A NEW study published in the Annals of Internal Medicine has found that semaglutide is linked to a reduced need for medical care related to tobacco use disorder (TUD) in smokers suffering from type 2 diabetes.
-
PSA’s roadmap for growth
Thursday | Aug 1 2024FEDERAL Health Minister, Mark Butler, will officially launch the Pharmaceutical Society of Australia's (PSA) vision for the future of pharmacy at the PSA24 National Conference this week.
-
BMS’ Opdivo gets listed
Thursday | Aug 1 2024BRISTOL Myers Squibb's (BMS)Opdivo (nivolumab) is now listed on the PBS for resectable non-small cell lung cancer (NSCLC).
-
New peanut allergy model
Thursday | Aug 1 2024IN A world-first initiative, Australian babies with peanut allergies will be offered a treatment program through a new model aimed at transforming allergy care.
